TransMedics Group, Inc.
Develops the only FDA-approved warm perfusion technology for preserving donor organs.
TMDX | US
Overview
Corporate Details
- ISIN(s):
- US89377M1099
- LEI:
- Country:
- United States of America
- Address:
- 200 MINUTEMAN ROAD, 1810 ANDOVER
- Website:
- https://www.transmedics.com/
- Sector:
- Manufacturing
Description
TransMedics Group, Inc. is a commercial-stage medical technology company focused on transforming organ transplant therapy. The company's primary offering is the Organ Care System (OCS™), a portable extracorporeal warm perfusion and assessment technology. The OCS™ is the only platform approved by the U.S. FDA for preserving donor hearts, lungs, and livers for transplantation, including for Donation after Circulatory Death (DCD) hearts. This system is designed to overcome the time and distance limitations of traditional cold storage, aiming to increase organ utilization, improve clinical outcomes, and reduce transplant costs. TransMedics also provides the National OCS™ Program (NOP™), an end-to-end solution that combines the OCS™ technology with dedicated logistics and expert clinical services to support transplant centers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all TransMedics Group, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TransMedics Group, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TransMedics Group, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||